ASENDIN Drug Patent Profile
✉ Email this page to a colleague
When do Asendin patents expire, and what generic alternatives are available?
Asendin is a drug marketed by Lederle and is included in one NDA.
The generic ingredient in ASENDIN is amoxapine. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Asendin
A generic version of ASENDIN was approved as amoxapine by CHARTWELL RX on June 28th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ASENDIN?
- What are the global sales for ASENDIN?
- What is Average Wholesale Price for ASENDIN?
Summary for ASENDIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Patent Applications: | 6,050 |
DailyMed Link: | ASENDIN at DailyMed |

US Patents and Regulatory Information for ASENDIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ASENDIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-002 | Approved Prior to Jan 1, 1982 | 3,681,357 | ⤷ Try for Free |
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Try for Free |
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-003 | Approved Prior to Jan 1, 1982 | 3,681,357 | ⤷ Try for Free |
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-004 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Try for Free |
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-003 | Approved Prior to Jan 1, 1982 | 3,663,696 | ⤷ Try for Free |
Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-004 | Approved Prior to Jan 1, 1982 | 3,681,357 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ASENDIN
See the table below for patents covering ASENDIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 252925 | ⤷ Try for Free | |
Israel | 27860 | THERAPEUTIC COMPOSITION CONTAINING 2-CHLORO-11-(1-PIPERAZINYL)-DIBENZ (B,F) (1,4) OXAZEPINE FOR THE TREATMENT OF DEPRESSION | ⤷ Try for Free |
Israel | 29571 | 11-SUBSTITUTED DIBENZO(B,F)-1,4-OXAZEPINES,DIBENZO(B,F)-1,4-THIAZEPINES AND DIBENZO(B,E)-1,4-DIAZEPINES AND THEIR PREPARATION | ⤷ Try for Free |
Switzerland | 485750 | Verfahren zur Herstellung basisch substituierter Heterocyclen | ⤷ Try for Free |
Switzerland | 450424 | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine | ⤷ Try for Free |
Brazil | 6457122 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for Asenapine (Asendin)
More… ↓